Microvasculaire schade en cognitieve achteruitgang bij type-1-diabetes

Brands, A.M., Biessels, G.J., de Haan, E.H., Kappelle, L.J. & Kessels, R.P. (2005). The Effects of Type-1-diabetes on Cognitive Performance: A meta-analysis. Diabetes Care 28: 726–735.

Brands, A.M., Kessels, R.P., Hoogma, R.P., et al. (2006). Cognitive performance, psychological well-being, and brain magnetic resonance imaging in older patients with type-1-diabetes. Diabetes 55: 1800–1806.

Chabriat, H., Sachon, C., Levasseur, M., et al. (1994). Brain metabolism after recurrent insulin induced hypoglycaemic episodes: a pet study. J Neurol Neurosurg Psychiatry 57: 1360–1365.

Cranston, I., Reed, L.J., Marsden, P.K. & Amiel, S.A. (2001). Changes in regional brain (18)F-fluorodeoxyglucose uptake at hypoglycemia in type 1 diabetic men associated with hypoglycemia unawareness and counter-regulatory failure. Diabetes 50: 2329–2336.

DeCarli, C., Murphy, D.G., Tranh, M., et al. (1995). The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy adults. Neurology 45: 2077–2084.

De Jong, R., (1950). The nervous system complications in diabetes mellitus with special reference to cerebrovascular changes. J Nerv Ment Dis 111: 181–206.

De la Torre, J.C. & Mussivand, T. (1993). Can disturbed brain microcirculation cause Alzheimer's disease? Neurol Res 15: 146–153.

Dow, C., Seidenberg, M. & Hermann, B. (2004). Relationship between information processing speed in temporal lobe epilepsy and white matter volume. Epilepsy Behav 5: 919–925.

Farkas, E. & Luiten, P.G. (2001). Cerebral microvascular pathology in aging and Alzheimer's disease. Prog Neurobiol 64: 575–611.

Ferguson, S.C., Blane, A., Perros, P., et al. (2003). Cognitive ability and brain structure in type-1-diabetes: relation to microangiopathy and preceding severe hypoglycemia. Diabetes 52: 149–156.

Filley, C. (2001). The behavioral neurology of white matter. Oxford University Press, New York.

Fulesdi, B., Limburg, M., Bereczki, D., et al. (1997). Impairment of cerebrovascular reactivity in long-term type-1-diabetes. Diabetes 46: 1840–1845.

Greene, D.A., Lattimer, S.A. & Sima, A.A. (1987). Sorbitol, phosphoinositides, and sodium-potassium-atpase in the pathogenesis of diabetic complications. N Engl J Med 316: 599–606.

Johnson, P.C., Brendel, K. & Meezan, E. (1982). Thickened cerebral cortical capillary basement membranes in diabetics. Arch Pathol Lab Med 106: 214–217.

Kalaria, R.N. & Hedera, P. (1995). Differential degeneration of the cerebral microvasculature in Alzheimer's disease. Neuroreport 6: 477–480.

Kaplan, J.G., Katzman, R., Horoupian, D.S., Fuld, P.A., Mayeux, R. & Hays, A.P. (1985). Progressive dementia, visual deficits, amyotrophy, and microinfarcts. Neurology 35: 789–796.

Kawamura, J., Meyer, J.S., Terayama, Y. & Weathers, S. (1991). Leukoaraiosis correlates with cerebral hypoperfusion in vascular dementia. Stroke 22: 609–614.

Keymeulen, B., Jacobs, A., de Metz, K., de Sadeleer, C., Bossuyt & A., Somers, G. (1995). Regional cerebral hypoperfusion in long-term type 1 (insulin-dependent) diabetic patients: relation to hypoglycaemic events. Nucl Med Commun 16: 10–16.

Kobari, M., Meyer, J.S. & Ichijo, M. (1990). Leuko-araiosis, cerebral atrophy, and cerebral perfusion in normal aging. Arch Neurol 47: 161–165.

Kovari, E., Gold, G., Herrmann, F.R., et al. (2004). Cortical microinfarcts and demyelination significantly affect cognition in brain aging. Stroke 35: 410–414.

Kuhl, D.E., Metter, E.J., Riege, W.H. & Hawkins, R.A. (1984). The effect of normal aging on patterns of local cerebral glucose utilization. Ann Neurol 15 Suppl: S133–137.

MacLeod, K.M., Hepburn, D.A., Deary, I.J., et al. (1994), Regional cerebral blood flow in iddm patients: effects of diabetes and of recurrent severe hypoglycaemia. Diabetologia 37: 257–263.

MacLeod, K.M., Gold, A.E., Ebmeier, K.P., et al. (1996). The effects of acute hypoglycemia on relative cerebral blood flow distribution in patients with type I (insulin-dependent) diabetes and impaired hypoglycemia awareness. Metabolism 45: 974–980.

Marchal, G., Rioux, P., Petit-Taboue, M.C., et al. (1992). Regional cerebral oxygen consumption, blood flow, and blood volume in healthy human aging. Arch Neurol 49: 1013–1020.

Mielke, R., Herholz, K., Grond, M., Kessler, J. & Heiss, W.D. (1992). Severity of vascular dementia is related to volume of metabolically impaired tissue. Arch Neurol 49: 909–913.

Miles, W. & Root, F. (1922). Psychologic tests applied to diabetic patients. Archives of Internal Medicine 30: 769–777.

Reichard, P., Berglund, B., Britz, A., Cars, I., Nilsson, B.Y. & Rosenqvist, U. (1991). Intensified conventional insulin treatment retards the microvascular complications of insulin-dependent diabetes mellitus (IDDM): the Stockholm Diabetes Intervention Study (sdis) after 5 years. J Intern Med 230: 101–108.

Reiche, W., Weiller, C., Weigmann, R., et al. (1991). [A comparison of mrt and spect findings in patients with cerebral microangiopathy]. Nuklearmedizin 30: 161–169.

Reske-Nielsen, E., Lundbaek, K. & Rafeisen, Q.J. (1965). Pathological changes in the cerebral and peripheral nervous system of young long-term diabetics. Diabetic encephalopathy. Diabetologia 1: 233–241.

Ryan, C.M., Geckle, M.O. & Orchard, T.J. (2003). Cognitive efficiency declines over time in adults with Type-1-diabetes: effects of micro- and macrovascular complications. Diabetologia 46: 940–948.

Ryan, C.M., Williams, T.M., Orchard, T.J. & Finegold, D.N. (1992). Psychomotor slowing is associated with distal symmetrical polyneuropathy in adults with diabetes mellitus. Diabetes 41: 107–113.

Sabri, O., Hellwig, D., Schreckenberger, M., et al. (2000), Influence of diabetes mellitus on regional cerebral glucose metabolism and regional cerebral blood flow. Nucl Med Commun 21: 19.

Sabri, O., Ringelstein, E.B., Hellwig, D., et al. (1999). Neuropsychological impairment correlates with hypoperfusion and hypometabolism but not with severity of white matter lesions on mri in patients with cerebral microangiopathy. Stroke 30: 556–566.

Sanfilipo, M., Lafargue, T., Rusinek, H., et al. (2002). Cognitive performance in schizophrenia: relationship to regional brain volumes and psychiatric symptoms. Psychiatry Res 116: 1–23.

Segel, S.A., Fanelli, C.G., Dence, C.S., et al. (2001). Blood-to-brain glucose transport, cerebral glucose metabolism, and cerebral blood flow are not increased after hypoglycemia. Diabetes 50: 1911–1917.

Snowdon, D.A., Greiner, L.H., Mortimer, J.A., Riley, K.P., Greiner, P.A. & Markesbery, W.R. (1997). Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. jama 277: 813–817.

Tallroth, G., Ryding, E. & Agardh, C.D. (1993). The influence of hypoglycaemia on regional cerebral blood flow and cerebral volume in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 36: 530–535.

The Diabetes Control and Complications Trial Research Group (1996). Effects of intensive diabetes therapy on neuropsychological function in adults in the Diabetes Control and Complications Trial. Ann Intern Med 124: 379–388.

Tomlinson, B.E., Blessed, G. & Roth, M. (1970). Observations on the brains of demented old people. J Neurol Sci 11: 205–242.

Wessels, A.M., Rombouts, S.A., Simsek, S., et al. (2006). Microvascular disease in type-1-diabetes alters brain activation: a functional magnetic resonance imaging study. Diabetes 55: 334–340.

Wessels, A.M., Simsek, S., Remijnse, P.L., et al. (2006). Voxel-based morphometry demonstrates reduced grey matter density on brain mri in patients with diabetic retinopathy. Diabetologia 49: 2474–2480.

Wong, T.Y., Klein, R., Klein, B.E., Tielsch, J.M., Hubbard, L. & Nieto, F.J. (2001). Retinal microvascular abnormalities and their relationship with hypertension, cardiovascular disease, and mortality. Surv Ophthalmol 46: 59–80.

Yamaguchi, T., Kanno, I., Uemura, K., et al. (1986). Reduction in regional cerebral metabolic rate of oxygen during human aging. Stroke 17: 1220–1228.

Yao, H., Sadoshima, S., Kuwabara, Y., Ichiya, Y. & Fujishima, M. (1990). Cerebral blood flow and oxygen metabolism in patients with vascular dementia of the Binswanger type. Stroke 21: 1694–1699.